Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Coronavirus RT-PCR Assay Receives CE Mark for Saliva Use, Sample Pooling

NEW YORK  – PerkinElmer said on Thursday that its SARS-CoV-2 Real-time RT-PCR assay has received the CE-IVD mark for the use of saliva as a specimen type and for sample pooling.

The assay can now be used to pool up to five specimens collected from individuals suspected of having COVID-19 or from asymptomatic patients. The test initially received CE marking in the spring.

"To strike the right balance between keeping the world economy moving while ensuring safe practices, governments and private organizations are working tirelessly to increase the number of times individuals are tested for COVID-19,” PerkinElmer VP and General Manager of Diagnostics Masoud Toloue said in a statement. "We expect our newly released saliva-based collection and asymptomatic test solution will play a large role in this effort."

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.